ENDRA Life Sciences Inc. reported results from a clinical study assessing measurement consistency of its TAEUS Liver device for quantifying liver fat in steatotic liver disease. The study included 14 subjects and 56 measurements performed by independent operators, and reported an intraclass correlation coefficient of 0.89 and a standard error of measurement of 3.3%. The company stated that the results have already been reported in the announcement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202602260800BIZWIRE_USPR_____20260226_BW198097) on February 26, 2026, and is solely responsible for the information contained therein.
Comments